NowRx Stock

nowrx.comHealthcare / Healthcare providers & servicesFounded: 2015Funding to Date: $114.11MM

NowRx, founded in 2015, is a technology-enabled pharmacy that uses proprietary pharmacy software, robotics, AI, and last-mile logistics to provide free same-day delivery of prescription medications. NowRx is a retail pharmacy just like any other, except instead of customers coming into the store to pick up their medications, they are delivered in hours - free of charge.

Register for Details

For more details on financing and valuation for NowRx, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for NowRx.

Register Today

NowRx investors also invested in these private companies

Decathlon Capital Partners
Ulu Ventures
Visary Capital
Gershon Capital
Logical Venture Partners
Envlp Ventures


Management Team

Cary Breese
Co-Founder & Chief Executive Officer
Sumeet Sheokand
Co-Founder & Chief Technology Officer
Mark Marlow
Chief Financial Officer

Other companies like NowRx in the Healthcare providers & services sector

Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation

News Highlights

NowRx is bringing prescription delivery to your front door | Engadget
This growing company has turned to equity crowdfunding to expand their tech-powered pharmacy concept..
Prescription startup NowRx is crowdfunding its latest $73 million funding round. Here's why CEO Cary Breese decided to avoid VCs.
NowRx's CEO sees several benefits to crowdfunding, like not getting pressure from VCs to scale too quickly and gaining a marketing advantage.
NowRX Returns to SeedInvest For Series C Funding in Reg A+ Offering
NowRX, has returned to SeedInvest for its Series C funding round. According to the offering page, NowRX is raising capital at a pre-money valuation of $275 million. The size of the round is indicative of the ability for more mature firms to raise capital online. This is the 4th time NowRX has utilized the SeedInvest platform with its Seris B round raising around $20 million – SeedInvest’s largest securities offering to date.
Updated on: Oct 3, 2023


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.